NEW DELHI / BENGALURU: India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world’s second-worst affected country struggles to contain the outbreak. The Indian government is pinning its hopes of mass supply of …
Read More »
Serum Institute of India, Pune became the second company after Pfizer to apply for an emergency use authorization for its trial vaccine, the Oxford COVID-19 vaccine (called COVISHIELD) in the country. The vaccine is currently undergoing phase III testing in India and other parts of the world. The news, which …
Read More »
After the Indian arm of US pharmaceutical giant Pfizer Inc, the Pune-based Serum Institute of India, on Sunday became the first indigenous company to apply for an emergency use authorization for the Oxford Covid-19 vaccine in the country. The Pune-based company has collaborated with Great Britain’s Oxford University and pharmaceutical …
Read More »
The Serum Institute of India on Sunday became the first indigenous company to submit an application to the Comptroller General of Drugs of India (DCGI) seeking an emergency use authorization for the Oxford Covid-19 vaccine in the country citing needs. not covered due to the pandemic and in interest. from …
Read More »
Adar Poonawalla is the CEO of the world’s largest vaccine manufacturer, Serum Institute of India. Singapore: Adar Poonawalla, CEO of the Serum Institute of India, the world’s largest vaccine manufacturer, is among the six people named “Asians of the Year” by Singapore’s leading daily, The Straits Times, for his work …
Read More »
Adar Poonawalla, CEO of the world’s largest vaccine maker, Serum Institute of India, is among six people named “Asians of the Year” by Singapore’s leading daily, The Straits Times, for his work in fighting the pandemic. of Covid-19. Pune-based Serum Institute of India (SII) has collaborated with Oxford University and …
Read More »
New Delhi: An investigation launched by the Comptroller General of Drugs of India (DCGI) into an alleged “serious adverse event” suffered by an Oxford COVID-19 The participant of the vaccine trial in Chennai found that it was not related to the injection he was given, official sources said. The DCGI …
Read More »
Written by Kaunain Sheriff M | New Delhi | Updated: December 2, 2020 7:52:43 am At the Serum Institute of India on Monday. (Photo: Reuters) UNDERLINING THAT several controls have been put in place to track adverse reactions reported in clinical trials for the Covid vaccine candidate being developed by …
Read More »
After a Chennai man claimed he suffered from neurological and psychological side effects after taking Covishield COVID-19 During human trials, the Serum Institute of India reaffirmed Tuesday that the Covishield vaccine is safe and immunogenic and that the company has followed all necessary regulatory and ethical processes diligently, before proceeding …
Read More »
The initial findings did not require stopping trials of the Oxford Covid-19 vaccine, he said. “Every time a clinical trial begins, subjects are expected to sign a prior informed consent form. This is a worldwide practice, it occurs in all countries. The form informs the subject about possible adverse events …
Read More »